drugset / Trial / NCT00759941
A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to assess the efficacy of adding Azopt dosed three times a day to Xalatan as compared to that of adding placebo to Xalatan in patients with elevated intraocular pressure.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brinzolamide | Small molecule | 1 % | Other |
| Background | Latanoprost | Small molecule | 0.005 % | Other |